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Summary
Iron regulatory proteins (IRPs) control the translation
of proteins involved in iron uptake, storage and utili-
zation by binding to specific noncoding sequences
of the corresponding mRNAs known as iron-respon-
sive elements (IREs). This strong interaction assures
proper iron homeostasis in animal cells under iron
shortage. Conversely, under iron-replete conditions,
IRP1 binds a [4Fe-4S] cluster and functions as cyto-
solic aconitase. Regulation of the balance between
the two IRP1 activities is complex, and it does not
depend only on iron availability. Here, we report the
crystal structure of human IRP1 in its aconitase form.
Comparison with known structures of homologous
enzymes reveals well-conserved folds and active
site environments with significantly different surface
shapes and charge distributions. The specific features
of human IRP1 allow us to propose a tentative model of
an IRP1-IRE complex that agrees with a range of previ-
ously obtained data.
Introduction
Iron is essential to all mammalian cells, and, after being
absorbed from the diet, it is distributed throughout the
body, with a large proportion directed to the oxygen
binding site of hemoglobin. Any intestinal absorption im-
balance or defective distribution results in disorders
such as hemochromatosis or anemia. Regulatory mech-
anisms of iron absorption are beginning to be under-
stood (Hentze et al., 2004). Extracellular iron normally
circulates in the plasma bound to transferrin, and cellu-
lar iron distribution must be properly managed to avoid
deleterious accumulations or shortages as observed in
the disorders mentioned above. One major regulatory
mechanism of cellular iron metabolism involves two
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(J.C.F.-C.)cytosolic iron regulatory proteins (IRP1 and IRP2) that
bind to specific stem-loop structures, the iron-responsive
elements (IREs), located at either the 50 or the 30 end of
the mRNA of proteins like ferritin and transferrin receptor
(Pantopoulos, 2004).
Unlike IRP2, IRP1 has two activities: it can either bind
to IREs, or it can assemble a [4Fe-4S] cluster and func-
tion as a cytosolic aconitase (cAcn), catalyzing the con-
version of citrate to isocitrate (Haile et al., 1992). The ac-
tual involvement of IRP1 in iron metabolism remains to
be fully established, and its capacity to substitute for
IRP2 in the regulation of iron homeostasis is being ad-
dressed with IRP2-deficient mice (Cooperman et al.,
2005; Galy et al., 2005). Under normal conditions, IRP1
seems to be mainly present as cAcn in tissues (Meyron-
Holtz et al., 2004). The enzymatic form is likely to contrib-
ute to cell defense against oxidative stress by providing
the isocitrate substrate to NADP-dependent isocitrate
dehydrogenase, which is one of the major producers of
NADPH in the cytosol (Lee et al., 2002). NADPH is used
by glutathione reductase to regenerate reduced glutathi-
one, which may be oxidized by glutathione peroxidase to
remove oxidative stress-induced H2O2.
A variety of cellular responses to changing environ-
mental conditions are associated with a switch of IRP1
activity between its two active forms resulting from the
assembly/disassembly of the [4Fe-4S] cluster. Cluster
disassembly triggers the conversion to the IRE binding
form upon iron starvation or under oxidative stress pro-
duced by reactive oxygen (Pantopoulos et al., 1997) or
nitrogen species (Drapier et al., 1993). As apo-protein,
IRP1 enhances iron mobilization and signals the need for
more uptake by both blocking the translation of ferritin
mRNA and stabilizing the transferrin receptor mRNA
(Haile et al., 1992). However, an excess of cellular iron
may be toxic due to its participation in Fenton-type re-
dox chemistry, leading to the production of highly reac-
tive hydroxyl radicals (Hentze et al., 2004). Because iron
deficiency also affects the proper functioning of the cell,
the IRE binding activity of IRP1 requires strict regulation.
If many of the enzymatic activities important for the bi-
ological synthesis of iron-sulfur centers have been iden-
tified (Lill and Muhlenhoff, 2005), little is known about
the cellular factors that directly trigger the ‘‘iron-sulfur
switch’’ of IRP1 and its detailed mechanism, except for
evidence that this posttranscriptional event is associ-
ated with sizeable structural changes affecting the entire
protein (Brazzolotto et al., 2002). One major obstacle to
fully understand the unusual behavior of this bifunc-
tional protein is the lack of a eukaryotic IRP structure.
We have recently communicated the crystallization of
human IRP1 in its aconitase form (Dupuy et al., 2005).
Here, we report the structure of this protein in two differ-
ent crystal forms, we analyze the major differences with
mitochondrial and bacterial aconitases, and we de-
scribe the results of manual docking of an IRE into the
IRP1 structure. To our knowledge, this is the first struc-
ture of a mammalian IRP. The model reveals some of the
key features that allow this protein to switch activities
depending on cell requirements.
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Structure Description
The fold of the cAcn form of human IRP1 is similar to that
of the w20% smaller mammalian mitochondrial en-
zymes (mAcn) (Lauble et al., 1992; Robbins and Stout,
1989), in spite of an overall sequence identity of only
about 22%. Each protein is composed of four globular
domains, with an extended linker segment located at
the protein surface that joins domains 3 and 4 (Figure 1).
The [4Fe-4S] cluster lies close to the center of the mole-
cule at the interface of the four domains. We have solved
the structures of three crystallographically independent
molecules of human cAcn: one in an orthorhombic
(C2221) and two in a monoclinic crystal (P21) form. A Zn
site is present only in the C2221 form (Dupuy et al.,
2005). As this site is involved in crystal packing, no func-
tional relevance can be attributed to it.
Superposition of the refined models of the two cAcn
crystal forms gives rms deviations that vary from
0.22 A˚ to 0.35 A˚ when it is applied domain by domain. If
entire molecules are superimposed, significantly higher
rms deviations of 0.39 A˚ and 0.52 A˚ are obtained. A com-
parison with bovine mAcn (Table 1) shows that more
than 90% of the Ca atoms of its domains 2, 3, and 4
can be closely superimposed to human cAcn, although
the sequence identity is only about 30%. All insertions/
deletions and other local differences are indicated in
the structure-based sequence alignment given in Fig-
ure 2. Human IRP2, which is 61% identical to IRP1, is
also included in this figure. The sequences of other
mammalian IRP1s are more than 92% identical to the
human protein, whereas chicken IRP1 is 87% identical.
Because, in addition, most of the substitutions are con-
servative and there are no insertions or deletions, all of
these IRP1s are expected to have essentially the same
structure.
A different fold is observed for the N-terminal region of
domain 1 of cAcn (residues 1–33) when compared to
mAcn. This may be described as a small subdomain
that comprises two short 310 helices and the two anti-
parallel b strands b1 and b2 (Figures 1B, 1C, and 2). Ac-
cordingly, the first long a helix of mAcn is absent from
cAcn, whereas the second one (a1 in cAcn) is much lon-
ger. This is followed by a first insertion (residues 47–72)
that includes helices a2 and a3. Two additional inser-
tions in domain 1 (residues 103–113 and 188–196) com-
prise an extension of helix a4, the short 310 helix h4, and
the two antiparallel b strands b7 and b8 that pack against
the N-terminal subdomain. Domain 3 contains two inser-
tions: residues 395–425, ending with b strands b18 and
b19, and residues 515–521, containing helix a18. An-
other long insertion is located in domain 4 (residues
686–708) and comprises helices a25 and h12. In addi-
tion, the linker in cAcn is about 20 residues longer than
in mAcn, and it is also more structured. Because all of
these insertions are exposed, the shapes of cAcn and
mAcn are significantly different, which explains the dis-
similar RNA binding properties of the two proteins.
A high structural similarity also exists between about
66% of domain 4 of cAcn and 95% of the small subunit
of Pyrococcus horichoshii isopropylmalate isomerase
(Ipmi) (Yasutake et al., 2004), another member of the
Fe-S isomerase family (Gruer et al., 1997). The structuralsuperposition is not as good between cAcn and aconi-
tase B (AcnB) from Escherichia coli. This protein has an
extra N-terminal HEAT-like region, a different domain or-
der (Table 1), and a short linker between its second and
third domains (Williams et al., 2002). About 86% of the
Ca atoms of its relatively short domain 3 and 91% of its
domain 5 can be closely superimposed to cAcn domains
1 and 3, respectively. Significantly lower values are ob-
tained when the other two cAcn domains are compared.
Substrate Accessibility
The crystal structure is in a closed conformation that
does not allow access and release of the tricarboxylic
acid substrates and products to and from the [4Fe-
4S]-containing active site of cAcn. Access to the active
site may be generated through a movement of domain
4 with respect to the other domains, as proposed for
mAcn (Beinert et al., 1996); it is therefore relevant to an-
alyze the interdomain contacts (Table 2). The main body
of domain 4, to be called domain 4a, is composed of res-
idues 660–865 and consists of a b barrel next to a mostly
a-helical region. This subdomain makes an extensive,
mainly polar contact interface with the three N-terminal
domains. A C-terminal a-helical appendix (residues
866–889) called domain 4b is packed against domain 1,
but here the contacts are mostly hydrophobic in nature.
Because exposure of a hydrophobic surface to the sol-
vent is thermodynamically unfavorable, the C-terminal
appendix might serve as an anchor during the proposed
movement of domain 4.
An electrostatic potential map reveals a remarkable
concentration of positive charges at the surface of do-
mains 1–3 facing domain 4a (Figure 1D), between two
extensive negatively charged patches that are located
in domains 1 and 3, respectively. There is a partially con-
nected network of hydrophilic cavities that follows the
long positive patch at the domain interface (Figure 1E).
This network is likely to be involved in guiding the nega-
tively charged substrates and products citrate, cis-aco-
nitate, and isocitrate to and from the active site. A small
rotation of domain 4 about some point in the hydropho-
bic contact interface, which is formed between its C-ter-
minal appendix and domain 1, would suffice to expand
the cavities enough to allow access of the substrates
to the active site.
The positive patch contains residues from each of the
three N-terminal domains that can be separated into two
groups. The first one involves four basic residues, H126,
H207, R536, and R541, that, together with two basic res-
idues from domain 4a, R713 and R780, surround the
substrate binding site. These six residues are conserved
in the mitochondrial and bacterial aconitase sequences
and also in IRP2. The second group involves five more
distant basic residues, R149, R153, K266, R269, and
R375, which are invariant in IRP2 but are not conserved
in bovine or in pig mAcn or in E. coli AcnB. A comparison
of the surface charge distributions of cAcn and mAcn
(data not shown) confirms that significant differences
between the two proteins exist outside the active site
pocket.
The Active Site
All residues surrounding the active site cavity are strictly
conserved between cAcn, mAcn, and AcnB. It is thus not
Crystal Structure of Human Cytosolic Aconitase
131Figure 1. Polypeptide Fold of Human Cytosolic Aconitase
(A) Domain organization: a helices are shown as spirals, a long central 310 helix (h5) is shown as a cylinder, and b strands are shown as arrows.
The central [4Fe-4S] cluster is shown in black.
(B) A different view (see also Figure S1), with domain 4 in front of domains 1–3. Regions with the same fold as in bovine mitochondrial aconitase
(mAcn) are shown in light gray. Two phosphorylation sites, S138 and S711 (Eisenstein et al., 1993), are shown in violet, whereas a star marks the
location of a 73 residue insertion in human IRP2.
(C) Stereopicture of a Ca trace of cAcn (in blue), in the same view as that in (A), superimposed to that of mAcn (in red).
(D) Electrostatic potential maps (blue, positive; red, negative). Domain 4 is rotated by 180º around the horizontal axis to highlight the surface
facing domains 1–3; it is shown in the same view as in (B).
(E) Zoom of a cavity map (pink, transparent) in the same view as (B), showing a tunnel at the interface of domains 1, 3, and 4 leading to the sub-
strate binding site labeled with ‘‘cav.’’ The map is calculated with an accessible probe radius of 1.2 A˚ for molecule 1 of the monoclinic crystal
form.
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132Table 1. Ca Superposition Statistics for the Comparison of Human cAcn with Other Enzymes
Protein A (Domain) Protein B (Domain) N(sup) % (A) % (B) Drms (A˚) % Ident
cAcn 34–240 (1) mAcn 35–200 (1) 154 74.4 92.8 1.26 32.5
cAcn 241–368 (2) mAcn 201–320 (2) 111 86.7 92.5 1.63 33.3
cAcn 369–591 (3) mAcn 321–500 (3) 163 73.1 90.6 1.64 28.8
cAcn 660–887 (4) mAcn 550–752 (4) 197 86.4 97.0 1.38 27.4
cAcn 660–885 (4) Ipmi 1–156 148 65.5 94.8 1.67 30.4
cAcn 34–240 (1) AcnB 381–529 (3) 128 61.8 85.9 1.68 16.4
cAcn 241–368 (2) AcnB 530–680 (4) 89 69.5 58.9 1.91 24.7
cAcn 369–566 (3) AcnB 681–820 (5) 128 64.6 91.4 1.89 25.0
cAcn 663–878 (4) AcnB 166–343 (2) 137 63.4 77.0 2.02 19.7
N(sup): number of superimposed residues; % (A, B): corresponding percentage of the given residue ranges in protein A and B, respectively;
Drms: root mean square deviation; Ident: sequence identity; cAcn: cytosolic aconitase (molecule 1 of the P21 form); mAcn: bovine mitochondrial
aconitase (Lloyd et al., 1999); Ipmi: isopropylmalate isomerase small subunit (Yasutake et al., 2004); AcnB: E. coli aconitase B (Williams et al.,
2002).surprising that the active site structures are essentially
the same. The cAcn crystals used in this study grew from
a citrate-containing solution, and we expected, there-
fore, to be able to detect bound substrate. However,
for one of the cAcn molecules in the asymmetric unit
of the monoclinic crystal form, no clear electron density
corresponding to a substrate molecule was observed;
only a water or hydroxide ligand could be assigned to
the non-cysteine bound Fe of the cluster, completing its
tetrahedral coordination (Figure 3A). For the other mole-
cule, three isolated density features were observed
(Figure 3B), two of which are compatible with two car-
boxylate groups of the substrate, whereas the third one
may be assigned to both the third carboxylate and an
iron bound water ligand. The location of the three elec-
tron density peaks cannot be explained by the known
isocitrate and citrate binding modes observed for mAcn
(Lauble et al., 1992; Lloyd et al., 1999). It is likely that a
mixture of different binding modes of citrate, isocitrate,
and/or cis-aconitate is present in the crystal, precluding
an accurate modeling of these molecules.
Docking of an Iron-Responsive Element
Previous IRE docking studies have been attempted by
using the structure of mAcn as a model for human IRP1
(Gegout et al., 1999; Paraskeva and Hentze, 1996). How-
ever, the shape of cAcn is significantly different from
that of mAcn (Figures 1B and 1C), which led us to try
the docking of IRE on the actual IRP1 structure. For
the sake of simplicity, domains 1–3 were fixed, and only
rigid body movements were applied to domain 4a of
IRP1 and to the IRE, which was taken from the NMR
structure of a truncated and slightly modified human
ferritin IRE fragment (Addess et al., 1997). In this pro-
cess, we used the information obtained by Schlegl and
coworkers, who were able to localize the parts of homol-
ogous transferrin receptor IREs that are protected
from enzymatic or chemical cleavage upon binding to
IRP1 (Schlegl et al., 1997) (Figure 4A). Additional con-
straints came from the reported involvement or protec-
tion of several amino acid residues in the IRE complex,
based on site-directed mutagenesis (Butt et al., 1996;
Kaldy et al., 1999; Philpott et al., 1994), crosslinking
(Basilion et al., 1994), and footprinting studies of IRP1
(Gegout et al., 1999) (Table 3). Among the involved
amino acids, residues H126, R149, R536, R541, andR780 are part of the positive patch discussed above
at the interface between domain 4 and domains 1–3
(Figure 1D).
There is a striking similarity in the shape of the domain
4a surface that faces domains 1–3 and a part of the sur-
face of the IRE (Figure 4B), suggesting that, in the com-
plex, the latter may replace domain 4a. Because of the
pseudo 2-fold symmetry of the IRE structure, it can be
superimposed in two ways to domain 4a, with the loop
containing bases 13–18 pointing in opposite directions.
In one orientation, D137 and K141, which are exposed to
proteases in the IRE-IRP1 complex (Gegout et al., 1999),
are close to the 30 end of the docked IRE, whereas, in the
other orientation, they are highly exposed (Figure 4C).
Taking into account additional docking constraints (Ta-
ble 3), and assuming an anchoring function of the C-ter-
minal appendix during the rearrangement of domain 4,
the orientation with the loop pointing downward in
Figure 4C is preferred.
The docked IRE packs closely against R149, R153,
R269, R536, and R541 of domains 1–3 (Figure 4D).
Some of these residues were already predicted to be in-
volved in IRE binding (Table 3). However, a significant lo-
cal structural change of the IRE is required to allow its in-
teraction with S127 (Basilion et al., 1994). If the structure
of the truncated IRE is extended in the 50 direction, it
could also contact R375 and K266. F88, a residue con-
served in IRP2 (but not in mAcn), could stack with one
or two bases in the IRE loop. In addition, the exposed
F399 and F538 that are conserved in IRP2 (but not in
mAcn) might interact with some of the bases that are lo-
cated in the 50 end of the IRE. However, these bases are
not present in the truncated NMR structure (Addess
et al., 1997).
Figure 4E depicts a rigid body movement of domain 4a
consisting of a 21º rotation and a center of mass trans-
lation of 22 A˚. This requires a rearrangement of a30 in or-
der to connect the last residue of domain 4a to the fixed
C-terminal anchor. The combined movements expose
R721, R728, R732, and R780, which may directly interact
with the negatively charged phosphates of the IRE
(Figure 4F). Our docking model satisfies the predicted
contact of the 685–689 region of domain 4 with the IRE
loop (C13–C18) and of its 732–737 region with the con-
served cytidine bulge (C7) (Kaldy et al., 1999), although
a specific contact with C7 has been questioned more
Crystal Structure of Human Cytosolic Aconitase
133Figure 2. Structure-Based Sequence Alignment of Human IRP1/cAcn, IRP2, and Bovine mAcn
Secondary structure elements are indicated with spirals for a helices and 310 helices and arrows for b strands; they are labeled for cAcn on the top
line (using h for 310 helices) and are shown for mAcn on the bottom line. Gaps are shown as dots. XXX corresponds to a 73 amino acid insertion in
IRP2; ZZZ indicates regions of mAcn for which there is no close structural similarity with cAcn.
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134Table 2. Selected Contacts between Domain 4 and Domains 1–3
Polar Contacts Mixed Contacts Nonpolar Contacts
Atom 1 Atom 2 D (A˚) Atom 1 Atom 2 D (A˚) Atom 1 Atom 2 D (A˚)
D678Od2 R541Nh1 3.3 S674Og F399Cz 3.6 G710C F88Ce2 3.5
N707Nd2 N150Od1 3.1 S708Og F88Cz 3.5 G714Ca V95Cg2 3.8
Q737Ne2 Q539Oe2 3.3 S711O R153CD 3.0 G810C I224Cd1 3.6
E773Oe2 R269Nh1 3.9 R713CD F88O 3.2 M811Sd I224Cd1 3.7
S778N R536Nh1 3.7 R728CD E539O 3.2 I879Cg2 I224Cb 3.8
D781Od2 I224N 2.8 G777C R536Nh2 3.3 M883Cb M100Ce 3.6
K785Nz D96Od2 2.6 S779Og D205Ca 3.4 I884Cg2 L107Cd1 3.6
E801Oe1 R269Nh2 2.6 Y800O V274Cg1 3.7 M887Cg I114Cd1 3.8
R802Nh1 G220O 2.7 I803Cg1 G220O 3.6 A888Cb L107Cb 3.8
Q846Ne2 N73Od1 3.1 N807Nd2 G222Ca 3.2
T867Og1 S236Og 2.8 D868Cg E75Oe1 3.3
Y873Oh Q233Oe1 2.6 V869Cb S236Og 3.6
L880Cd1 E227Oe1 3.3
Y882Ce2 Q233Oe1 3.8recently (Meehan and Connell, 2001). Additional data
supporting our model are provided in the Supplemental
Data (available with this article online).
Discussion
To our knowledge, this is the first report of the structure
of a mammalian cytosolic aconitase (cAcn/IRP1). Thestructure may be used as a basis to investigate which
changes allow it to bind IREs and turn it into a regulator
of the translation of mRNAs coding for proteins that are
involved in iron homeostasis. The structural comparison
of the three cAcn models obtained here shows smaller
rms deviations for a domain-by-domain superposition
than for a superposition of the entire molecule. This indi-
cates that different crystal packing interactions haveFigure 3. Stereopairs of the Active Site of the cAcn Form of Human IRP1 in the Monoclinic Crystal Form
(A) [4Fe-4S] cluster environment and a jFoj 2 jFcj omit map contoured at 4 (blue) and 12 s (black) in molecule 1.
(B) Substrate cavity (pink) and a jFoj 2 jFcj map (black grid shown at the 4 s contour level) in molecule 2. A modeled cis-aconitate molecule is
marked with gray bonds (see text). The cavity map was calculated with an accessible probe radius of 1.2 A˚.
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135Figure 4. Docking of a Ferritin H Chain IRE Fragment to IRP1
(A) Secondary structure of the IRE (Addess et al., 1997). Bases circled in red and riboses highlighted by a blue dot are predicted to be in contact
with IRP1 (Schlegl et al., 1997).
(B) Stereopicture of the superposition of the IRE (orange) with domain 4 (green), in the same view as Figure 1B.
(C) IRE docking against domains 1–3. Yellow, hydrophobic patch; green, involved in IRE binding or protected against proteolysis in the IRP1-IRE
complex (Table 3); pink, aromatic residues; red, exposed upon IRE binding (Gegout et al., 1999).
(D) Same view, with electrostatic potential map colored as in Figure 1D.
(E) View of the entire IRP1-IRE model in the same view as Figure 1A, with colors as in (C).
(F) Docking of domain 4 against IRE, with colors as in (C) and (D).
Structure
136Table 3. Literature Data about IRP1 Residues Involved in or Affected by IRE Binding
Amino Acid Residues Type of Evidence References
C437, C503, C506 Decreased IRE binding in mutants Philpott et al., 1994
R536, R541, R780 Decreased IRE binding in mutants Philpott et al., 1994; Butt et al., 1996
121–130 S127 is crosslinked to IRE Basilion et al., 1994
685–689, 732–737 Decreased IRE binding in mutants Kaldy et al., 1999
K79, D87, R101, D102, K105, K106, D125,
R149, E155, R187, R721, R728, R732, D751
Protected against proteolysis in complex Gegout et al., 1999caused small rigid body movements of the domains with
respect to each other. Such movements may reflect the
dynamic association of the domains in solution, and
they suggest their possible participation in the release
of the [4Fe-4S] cluster to convert the protein to the metal-
free regulatory form.
The structure of cAcn/IRP1 shows a network of par-
tially connected hydrophilic cavities at the interface of
domain 4 with the other domains (Figure 1E). This may
become a wider tunnel after a small movement of do-
main 4. The highly negatively charged citrate, cis-aco-
nitate, and isocitrate substrates and products may thus
gain access to and exit from the active site following
a long patch of positively charged residues at the do-
main interface (Figure 1D). In spite of its similar struc-
ture, mitochondrial aconitase may have a different sub-
strate access pathway because, except for the substrate
binding cavity, there are no conserved amino acid resi-
dues between cAcn and mAcn involved in the positive in-
terdomain surface patches. On the other hand, all of
these residues are conserved in IRP2, suggesting that
they might interact with the negatively charged phos-
phate groups of the recognized IREs.
A reorientation of specific amino acid side chains may
also play a role in allowing substrate access to the active
site. In fact, the different occupation of the substrate
cavity that is observed for the two cAcn molecules of
the monoclinic crystal form could be due to a reorien-
tation of R541. The electron density map suggests that
this residue is partially disordered, with a significantly
larger fraction pointing to the substrate cavity in mole-
cule 2 (Figure 3B). This corresponds to the conformation
found for mAcn in the isocitrate and citrate complexes
(Lauble et al., 1992; Lloyd et al., 1999). In the other orien-
tation, which appears to be the major one in molecule 1
and also in the C2221 crystal form, R541 cannot interact
with the substrate, and it leaves open a narrow tunnel
connecting the active site and the molecular surface
(Figures 1E and 3A). A similar rearrangement of the cor-
responding Arg residue has been observed for mAcn in
the absence of substrate or inhibitor molecules (Lauble
and Stout, 1995). The apparent disorder of this residue in
cAcn may also explain why the substrate/product elec-
tron density is not better defined. Clearly, more studies
are needed to obtain better structural information on
substrate binding to cAcn and to verify whether, as ex-
pected, it has the same catalytic mechanism as mAcn.
Another question that may be addressed here is why
IRP2 does not display aconitase activity, in spite of its
61% sequence identity with IRP1 (Guo et al., 1995). A
major difference is the 73 residue insertion in domain 1
(Figure 2) that is thought to form an additional domain
in IRP2 (Pantopoulos, 2004). There is no evidence for
the presence of a [4Fe-4S] cluster in IRP2. Moreover,S778 of IRP1, which in mAcn is proposed to provide
an alkoxyde that removes the Ca proton during dehy-
dration of the citrate substrate (Beinert et al., 1996)
(see also Figure 3), is substituted by asparagine in IRP2.
Both the replacement of the putative catalytic base by
a bulkier residue and the absence of the cluster are suf-
ficient to explain the absence of aconitase activity. A
further comparison of residues situated around the
[4Fe-4S] cavity in IRP1 shows substitution in IRP2 of
I176 by methionine and of S441 by cysteine (Figure 3).
The former replacement may leave insufficient space for
a cluster to be present in IRP2, whereas the latter one
points at the possibility that C437, one of the cluster
ligands, forms a disulfide bond with C441 in IRP2 (IRP1
numbering), which would also prevent cluster binding. In
the absence of a cluster, simple rotations of the side
chains of C503 and C506 would allow for disulfide bond
formation between these residues as well. A crystal
structure of IRP2 is needed to dismiss or confirm these
hypotheses.
A unique feature of human cAcn with respect to bovine
and pig mAcn is the presence of a hydrophobic contact
interface between the C-terminal appendix of domain 4
and helices a4 and a7 of domain 1 (Table 2) that may de-
fine an anchor and a hinge region for the domain 4 rigid
body rotations that are putatively involved in substrate
trafficking and IRE binding (Figure 4C). Another impor-
tant difference is a long insertion in domain 4 of cAcn
that includes helix a25 (Figures 1B and 2). This insertion
is directly involved in the structural superposition of
the loop region of human ferritin IRE and domain 4a
(Figure 4B). The absence of these features in mAcn
may be responsible for the apparent inability of this en-
zyme to bind efficiently to mRNA. Although it has been
reported that bacterial AcnB, which is also different in
this respect, is capable of binding to IRE-like stem-
loop RNA structures, it does it with association con-
stants that are many orders of magnitude lower than
the ones of human IRP1 (Williams et al., 2002). Yeast
mAcn, which is 68% identical to bovine mAcn, is involved
in stabilizing mitochondrial DNA (Chen et al., 2005), sug-
gesting that it may interact with double-stranded nucleic
acids. Considering that the IRE stem consists mainly of
double-stranded RNA (Figure 4), it remains to be investi-
gated whether the surfaces of AcnB and yeast mAcn
involved in DNA/RNA binding interactions are the same
or different from those of human IRP1.
Circular dichroism studies have shown that removal
of both the [4Fe-4S] cluster and the IRE from human
cAcn/IRP1 leads to loss of some of the secondary struc-
ture, and small-angle neutron scattering studies have
found increasing values for the radii of gyration of the se-
ries cAcn, IRP1-IRE complex, and apoenzyme (Brazzo-
lotto et al., 2002), indicating significant conformational
Crystal Structure of Human Cytosolic Aconitase
137Table 4. Data and Refinement Statistics
Crystal 1 Crystal 2 Crystal 3
Data Collection
Native Native + Kau(CN)2
Space group P21 C2221 C2221
Cell dimensions: a, b, c (A˚) 63.9, 215.5, 64.0 75.3, 103.3, 225.9 75.8, 103.2, 225.9
b (º) 72.0 90.0 90.0
Peak Inflection Remote
Wavelength (A˚) 0.939 1.739 1.741 1.283 1.040
Resolution (A˚) 20.0–1.85 25.0–2.88 25.0–2.89 47.0–2.54 47.0–2.50
Rsym 6.0 (26.2) 9.5 (33.6) 13.6 (55.7) 7.9 (23.1) 12.5 (34.8)
<I>/<s(I)> 8.6 (3.0) 10.7 (2.7) 7.7 (1.6) 11.1 (3.3) 13.3 (5.9)
Completeness (%) 97.5 (92.1) 94.5 (71.7) 92.9 (68.0) 94.6 (72.9) 99.9 (99.8)
Redundancy 2.0 3.6 3.3 3.5 7.6
Refinement
Resolution (A˚) 1.85 2.54
Number of reflections 131,161 27,179
Rwork/Rfree 21.1/26.1 18.0/22.5
Number of atoms
Protein 13,859 6,928
Ligand/ion 43 13
Water 970 168
B factors
Protein 27.6 32.7
Ligand/ion 33.6 27.6
Water 32.7 37.4
Rms deviations
Bond lengths (A˚) 0.011 0.010
Bond angles (º) 1.29 1.23
Crystals 2 and 3 were used for phasing of the C2221 form; the P21 form was solved by molecular replacement. Highest-resolution shells are
shown in parentheses.differences between these forms. In the model reported
here, we treated the IRE NMR structure as a rigid body
and only introduced a simple rigid body rearrangement
of domain 4a while keeping domains 1–3 fixed. However,
it is very likely that there will be local structural adapta-
tions of both IRP1 and the IRE. At any rate, our tentative
model is consistent with most of the results that have
been reported in the literature. Furthermore, the unex-
pected shape similarity between domain 4a and a region
of the IRE (Figure 4B) suggests that the structural
changes might be relatively small. A similar example of
‘‘molecular mimicry’’ is the close resemblance of the
tRNA in a complex with elongation factor Tu to three do-
mains of the translocation factor EF-G (Nissen et al.,
1995). A crystal structure of the actual IRP1-IRE complex
will be useful to assess the quality of our tentative model,
to describe the interaction between the two molecules in
more detail, and to understand better why no IRE binding
is possible when the iron-sulfur cluster is present.
IRP1 contains two phosphorylation sites, at S138 and
S711, that may regulate the relative concentration of the
cAcn and IRE binding forms in vivo (Eisenstein et al.,
1993). Accordingly, Fillebeen et al. (2003) have shown
that the phosphomimetic S138E mutation results in
loss of the aconitase activity, and that the mutant protein
is much more sensitive to iron-dependent proteolytic
degradation than native IRP1. Also, phosphorylation of
S711 was observed upon cell activation with phorbol
12-myristate 13-acetate, whereas the S711E phospho-
mimetic mutant did not display any activity in mamma-
lian cells (Fillebeen et al., 2005). The cAcn/IRP1 structure
does not shed much light on these processes becauseboth S138 and S711 are inaccessible to solvent. In the
case of the latter, a domain opening would be required
for it to bind phosphate (Figure S2).
The structure of human cAcn reported here allowed us
to identify some of the special features that make this
protein so functionally unusual among the Fe-S isomer-
ase family. Indeed, the very similar structural organiza-
tion of mAcn and cAcn does not justify by itself a major
difference between these two molecules. However,
most of the insertions scattered along the IRP1 se-
quence occur at the surface of the molecule, and they
significantly change the general shape of cAcn and
hence its potential interaction with partners, when com-
pared to mAcn (Figures 1B and 1C). Many of these fea-
tures are directly involved in the predicted interaction
with IRE (Figure 4). Consequently, the present study
may be useful for understanding the molecular basis
of pathological defects observed upon IRE mutations
that lead to cases of hyperferritinemia-cataract syn-
drome (Levi et al., 1998) and iron overload (Kato et al.,
2001). Thus, it may be a first step toward the develop-
ment of potential structure-based therapies against
the many iron homeostasis-related disorders (Hentze
et al., 2004; Pantopoulos, 2004).
Experimental Procedures
Structure Determination
Three crystals of human IRP1 (Table 4) were used to collect all X-ray
data, as described (Dupuy et al., 2005). Solution of anomalous differ-
ence Patterson maps of the C2221 form with SHELXD (Schneider
and Sheldrick, 2002) indicated the presence of one Fe and one Zn
site in the native crystal and, in addition, a major and minor gold
Structure
138site in the KAu(CN)2 derivative. Subsequent phasing was performed
with the program SHARP (de la Fortelle and Bricogne, 1997), by us-
ing MAD and SAD data on crystals 2 and 3 and modeling the [4Fe-4S]
cluster as a single heavy atom with a B factor of 80 A˚2. The first 2.9 A˚
resolution electron density map was of sufficient quality to distin-
guish protein from solvent zones, and a partially interpretable
map could be obtained after solvent flattening with the program
SOLOMON (Abrahams and Leslie, 1996; CCP4, 1994).
A very incomplete first model was constructed automatically with
the program RESOLVE (Terwilliger, 2000). Subsequent chain tracing,
performed manually with the graphics program TURBO (Roussel
and Cambillaud, 1989), was greatly facilitated by a superposition of
the 1.8 A˚ resolution model of bovine mitochondrial aconitase (Lloyd
et al., 1999) to the electron density map. Further phasing with
SHARP, including model phases, allowed for the construction of
an 82% complete model. This was used for molecular replacement
into the monoclinic crystal form with the program PHASER (Read,
2001). The model was further improved in the resulting 2.5 A˚ resolu-
tion electron density map of the P21 form and, finally, was back
transformed to and completed in the C2221 form.
Refinement
A low-resolution data cutoff of 8 A˚ was used for initial partial model
refinements with REFMAC (CCP4, 1994; Murshudov et al., 1997).
Once a complete atomic model was obtained, a Babinet model for
bulk solvent was included, and all the data were incorporated in
the refinement, excluding 5% for Rfree calculations. Atomic positions
and isotropic B factors were refined for both crystal forms. In addi-
tion, noncrystallographic symmetry restraints and translation libra-
tion screw parameters (Winn et al., 2001) were used for each of the
structural domains of the two IRP1 molecules in the P21 crystal form.
A PROCHECK analysis (Laskowski et al., 1993) showed that the
model was of high quality, as indicated by the distribution of the
main chain angles of more than 90% of the residues in the most fa-
vored regions of the Ramachandran plot for the C2221 crystal form
(data not shown). The final refinement statistics are given in Table 2.
Model Analyses
Superposition of the various structures was performed with the pro-
gram SUPPOS from the BIOMOL package (http://www.xray.chem.
rug.nl/Links/Biomol1.htm). MOLSCRIPT (Kraulis, 1991), CONSCRIPT
(Lawrence and Bourke, 2000), CAVENV (CCP4, 1994), RASTER3D
(Merritt and Bacon, 1997), and PyMOL (DeLano, 2002), which was
used for electrostatic potential calculations, were used to generate
figures.
Supplemental Data
Supplemental Data including an additional figure of the fold of hu-
man cytosolic aconitase, an electron density figure of the S711
phosphorylation site, and an additional paragraph supporting the
iron-responsive element docking model are available at http://
www.structure.org/cgi/content/full/14/1/129/DC1/.
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